0001209191-20-059839.txt : 20201120 0001209191-20-059839.hdr.sgml : 20201120 20201120201318 ACCESSION NUMBER: 0001209191-20-059839 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201118 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEWARD RANDALL J CENTRAL INDEX KEY: 0001067586 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 201334062 MAIL ADDRESS: STREET 1: C/O QUIDEL CORPORATION STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-18 0 0000353569 QUIDEL CORP /DE/ QDEL 0001067586 STEWARD RANDALL J 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2020-11-18 4 A 0 1034 0.00 A 3882 D Common Stock 2020-11-18 4 F 0 513 187.28 D 3369 D Restricted Stock Units 2020-11-18 4 M 0 1034 0.00 D Common Stock 1034 2066 D Reflects the release of restricted stock units that were previously reported on a Form 4. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Restricted stock units convert into common stock on a one-for-one basis. 1,034 shares vested on the first anniversary date of the grant date, November 18, 2020. 1,033 shares will vest on the second anniversary date of the grant date, November 18, 2021. 1,033 shares will vest on the third anniversary date of the grant date, November 18, 2022. Robert J. Bujarski, attorney-in-fact for Randall J. Steward 2020-11-20